Brightstar Associates LLC

Other

US·SEC (Form 4)

Deciphera Pharmaceuticals, Inc.

0

Total declarations

0

Company

€14m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Brightstar Associates LLC. Director active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been published. Total volume traded: €14.1m. The latest transaction was filed on 29 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Declarations1 total

Executives▲PurchaseDDeciphera Pharmaceuticals, Inc.14SEC

B

Brightstar Associates LLC

€14m1,478,978 shares@ €9.52100.0% of flow

Common Stock

SEC:0000899243-22-016029:0·29 Apr 2022

Ideal exit: 24 Jan 2023 (T+270)

SEC ↗

1 of 1 declaration